Y 90 Ibritumomab Tiuxetan &Rituximab Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Beth Israel Deaconess Medical Center
Related studies linked through entity extraction aliases.
Boron Neutron Capture Therapy in Treating Patients With Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Thalidomide in Treating Patients With Asymptomatic, Indolent Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Progesterone vs Placebo Therapy for Women With Epilepsy
- Status
- COMPLETED
- Phase
- PHASE3
Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance
- Status
- COMPLETED
- Phase
- NA
Gene Therapy in Treating Patients With Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Monoclonal Antibody Therapy in Treating Patients With Refractory Anaplastic Large Cell Lymphoma or Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- PHASE1
Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1
Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2